~~<i id='10354590D5'><strike id='10354590D5'><tt id='10354590D5'><pre id='10354590D5'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：comprehensive 2025-08-05 20:19:19 Page View：2835

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Vermont grapples with historic flooding as more rainstorms head for Northeast
Next article： Novavax promises a turnaround & Lilly roils the obesity market

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Teach medical students about patients with intellectual disabilities

AdobeOliverMcGowanwas18yearsoldwhenhewashospitalizedinEnglandwithrecurrentseizuresandpneumonia.Hewas

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Editor’snote:Arecordingoftheeventisembeddedbelow.Afterafewgo-goyears,theearly-stagebiotechmarkethasc

WSS

hotspot

hotspot

Wikipedia

leisure time

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D